REGULATED PRESS RELEASE published on 04/08/2025 at 08:30, 1 year 7 months ago Cie du Bois Sauvage: Buy back of own shares – week from 31/03/2025 to 04/04/2025 Cie du Bois Sauvage disclosed its share buy-back transactions from 31/03/2025 to 04/04/2025, totaling 544 shares purchased for €129,574.00. Details available on www.bois-sauvage.be Cie Du Bois Sauvage Share Buy-back NYSE Euronext Market Brussels Trading Regulation
REGULATED PRESS RELEASE published on 04/08/2025 at 08:15, 1 year 7 months ago Publication of the CNP Assurances Group and CNP Assurances SA Solo SFCRs at 31 December 2024 CNP Assurances Group and CNP Assurances SA release the solo SFCRs for 31 December 2024, meeting Solvency II requirements. Key points include SCR coverage ratios and financial data CNP Assurances Regulatory Compliance Financial Report SFCR Solvency
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Transaction in Own Shares Molten Ventures plc announces transaction in own shares as part of share repurchase program. Numis Securities bought 70,000 Ordinary Shares, highest price 235.00p, lowest 215.60p Ordinary Shares Molten Ventures Plc Numis Securities Share Repurchase Program Price
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Pulsar Helium Announces Execution of US$4 Million Project Finance Facility Line of Credit Note Pulsar Helium Inc. secures US$4 million project finance facility for Topaz Helium project in Minnesota from University Bancorp, Inc Pulsar Helium Inc. Topaz Helium Project Minnesota Finance Facility University Bancorp
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Quantum Genomics provides an update on its situation Quantum Genomics provides an update on trading suspension, search for a new business partner, and financial situation with impending yearly accounts release Financial Situation Trading Suspension Quantum Genomics Reverse Take Over Yearly Accounts Release
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 7 months ago Ondine Biomedical Inc. Announces Steriwave in First Swiss Hospital University Hospital Zurich conducts independent study on Steriwave for preoperative nasal decolonization, assessing efficacy in reducing microbial burden to combat surgical site infections (SSI) Nasal Decolonization Steriwave Clinical Study University Hospital Zurich Antimicrobial Photodynamic Therapy
PRESS RELEASE published on 04/08/2025 at 07:43, 1 year 7 months ago INSIDE INFORMATION / OTHER NEWS RELEASES GenSight Biologics announces the filing of its 2024 Universal Registration Document with the French market authority, including financial reports and corporate governance details GenSight Biologics Gene Therapies Retinal Neurodegenerative Diseases 2024 Universal Registration Document Central Nervous System Disorders
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases MaaT Pharma announces positive safety interim analysis from DSMB for Phase 2b trial evaluating MaaT033 for patients receiving Allo-HSCT, demonstrating favorable safety profile and tolerability Phase 2B Trial MaaT Pharma Safety Analysis MaaT033 Allo-HSCT
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 7 months ago BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025 BioVersys to present BV100 Phase 2 data at 35th ESCMID Global 2025. Oral presentation on positive VABP trial read-out & poster presentations on Acinetobacter baumannii & NTM data Clinical Data BV100 Antibacterial Products BioVersys ESCMID Global 2025
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 7 months ago Nyxoah Provides Update on FDA Approvable Letter for Genio System Nyxoah provides update on FDA Approvable Letter for Genio System, expecting full PMA approval in Q2 2025 after addressing final requirements FDA Nyxoah Genio System Approvable Letter PMA Approval
Published on 11/13/2026 at 15:40, 1 hour 40 minutes ago Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
Published on 11/13/2026 at 15:05, 2 hours 15 minutes ago ACCESS Newswire Continues to Repurchase its Shares
Published on 11/13/2026 at 15:00, 2 hours 20 minutes ago Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates
Published on 11/13/2026 at 14:00, 3 hours 20 minutes ago GameSquare's Hatchet Publishes TikTok Live for Gaming in H1 2026 Report
Published on 11/13/2026 at 16:15, 1 hour 5 minutes ago REPLOID explores potential for Austrian farmers and foresters to save hundreds of millions of euros annually in mineral oil tax with locally produced biodiesel from insect fat
Published on 11/13/2026 at 11:35, 5 hours 45 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/12/2026 at 23:12, 18 hours 7 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 18:36, 22 hours 43 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:00, 23 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026
Published on 11/12/2026 at 17:40, 23 hours 40 minutes ago Financial information for the period ended 30 September 2026
